MyHealthChecked plc (MHC) Ord 0.1p
MyHealthChecked plc, formerly Concepta PLC, is a United Kingdom-based women’s healthcare company. The Company offers a portfolio of at-home testing brands, which includes MyHealthChecked and Mylo. MyHealthChecked brand includes a range of at-home DNA and RNA tests deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Mylo brand is focused on the mobile health market, with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and providing insight to unexplained infertility. Its flagship product, myLotus is an advanced dual purpose monitoring system allowing both ovulation (LH) and pregnancy (hCG) testing. It offers myLotus ovulation test, which allows to test the Luteinising Hormone (LH) in women. The Company also offers its myLotus pregnancy test, which measure the presence of the pregnancy hormone human Chorionic Gonadotropin (hCG) in urine. Its Fertility App is an application that allows women to track fertility on mobile.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.